South Africa’s Biovac to receive $150M from development partners to fund expansion
Biovac , South Africa’s vaccine manufacturer has clinched a deal with a consortium of nine development finance institutions to raise $150M to fund the Cape Town based facility to produce up to 1- billion doses a year. This deal bolsters South Africa and the African continent to increase vaccine manufacturing capacity and reduce reliance on…